TURN THERAPEUTICS INC (TTRX) Stock Price & Overview
NASDAQ:TTRX • US90021W1053
The current stock price of TTRX is 3.38 USD. Today TTRX is down by -1.02%. In the past month the price decreased by -9.87%.
TTRX Key Statistics
- Market Cap
- 99.541M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
TTRX Stock Performance
TTRX Stock Chart
TTRX Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to TTRX.
TTRX Earnings
TTRX Forecast & Estimates
8 analysts have analysed TTRX and the average price target is 7.22 USD. This implies a price increase of 113.51% is expected in the next year compared to the current price of 3.38.
TTRX Groups
Sector & Classification
TTRX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TTRX Ownership
TTRX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 29.29 | 948.755B | ||
| JNJ | JOHNSON & JOHNSON | 20.57 | 591.001B | ||
| MRK | MERCK & CO. INC. | 21.45 | 298.537B | ||
| PFE | PFIZER INC | 8.86 | 151.354B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.98 | 126.888B | ||
| ZTS | ZOETIS INC | 17.8 | 55.509B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.81 | 27.378B | ||
| VTRS | VIATRIS INC | 5.79 | 16.937B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.74 | 12.151B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.393B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.67B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.517B | ||
| GPCR | STRUCTURE THERAPEUTICS INC | N/A | 4.459B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TTRX
Company Profile
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
Company Info
TURN THERAPEUTICS INC
250 North Westlake Blvd., #210
Westlake Village CALIFORNIA US
Employees: 0
Phone: 18185644011
TURN THERAPEUTICS INC / TTRX FAQ
What does TTRX do?
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
What is the stock price of TURN THERAPEUTICS INC today?
The current stock price of TTRX is 3.38 USD. The price decreased by -1.02% in the last trading session.
Does TTRX stock pay dividends?
TTRX does not pay a dividend.
How is the ChartMill rating for TURN THERAPEUTICS INC?
TTRX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the sector and industry classification for TURN THERAPEUTICS INC?
TURN THERAPEUTICS INC (TTRX) operates in the Health Care sector and the Pharmaceuticals industry.
Is TURN THERAPEUTICS INC (TTRX) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TTRX.